Cargando…
Targetability of the neurovascular unit in inflammatory diseases of the central nervous system
The blood–brain barrier (BBB) is a selectively permeable barrier separating the periphery from the central nervous system (CNS). The BBB restricts the flow of most material into and out of the CNS, including many drugs that could be used as potent therapies. BBB permeability is modulated by several...
Autores principales: | Smith, Brandon C., Tinkey, Rachel A., Shaw, Benjamin C., Williams, Jessica L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489669/ https://www.ncbi.nlm.nih.gov/pubmed/35909222 http://dx.doi.org/10.1111/imr.13121 |
Ejemplares similares
-
Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1
por: Smith, Brandon C., et al.
Publicado: (2023) -
Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases
por: Seillier, Célia, et al.
Publicado: (2022) -
Astrocyte Signaling in the Neurovascular Unit After Central Nervous System Injury
por: Huang, Lena, et al.
Publicado: (2019) -
Targeting cell surface receptors for axon regeneration in the central nervous system
por: Cheah, Menghon, et al.
Publicado: (2016) -
Cell replacement therapy for central nervous system diseases
por: Tso, Danju, et al.
Publicado: (2015)